Taylor C E, Sviland L, Pearson A D, Dobb M, Reid M M, Kernahan J, Craft A W, Hamilton P J, Proctor S
Department of Virology, Royal Victoria Infirmary, Newcastle upon Tyne.
J Clin Pathol. 1990 Aug;43(8):633-7. doi: 10.1136/jcp.43.8.633.
Over three years 81 consecutive bone marrow transplant recipients (32 allogeneic and 49 autologous) who received prophylaxis with acyclovir, were studied for symptomatic virus infection. Thirty nine infections were documented in a total of 28 patients. Thirty two infections were mild, five were moderately severe, and two were severe. Cytomegalovirus infection occurred in only six allogeneic recipients. Herpes simplex virus and varicella zoster virus infections occurred infrequently. Seven patients who were considered at the time of death to have died due to an infectious cause were studied virologically at necropsy. In only one patient was a virus infection thought to have been the cause of death. Prophylaxis with acyclovir may have influenced the rate and clinical prominence of herpes virus infections. In this study viruses were considered to have had a relatively minor role in causing morbidity and mortality.
在三年多的时间里,对81例连续接受阿昔洛韦预防治疗的骨髓移植受者(32例同种异体移植和49例自体移植)进行了有症状病毒感染的研究。共28例患者记录到39次感染。32次感染为轻度,5次为中度严重,2次为重度。巨细胞病毒感染仅发生在6例同种异体移植受者中。单纯疱疹病毒和水痘带状疱疹病毒感染很少发生。对7例在死亡时被认为死于感染原因的患者在尸检时进行了病毒学研究。仅1例患者的病毒感染被认为是死亡原因。阿昔洛韦预防治疗可能影响了疱疹病毒感染的发生率和临床严重程度。在本研究中,病毒被认为在引起发病和死亡方面作用相对较小。